Regeneron Pharmaceuticals (REGN) Return on Sales (2009 - 2026)
Regeneron Pharmaceuticals (REGN) posted quarterly Return on Sales of 0.0% for Q2 2026, little changed year-over-year from 0.0% in Q2 2025, and up 49.86% quarter-over-quarter from 0.0% in Q1 2026.
Regeneron Pharmaceuticals (REGN) Return on Sales (2009 - 2026) Analysis & Trends
Regeneron Pharmaceuticals' Return on Sales history runs 18 years deep, the most recent figure standing at 0.0% for Q2 2026.
- In Q2 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Jun 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Sales for Q2 2026 stood at 0.0%, up from 0.0% in the prior quarter.
- The five-year high for Return on Sales was 0.19% in Q1 2022, with the low at 0.0% in Q1 2026.
- The 5-year median for Return on Sales is 0.0% (2023), against an average of 0.02%.
- The sharpest annual moves came in 2022 and 2023: Return on Sales gained 19 bps in 2022, then retreated 19 bps in 2023.
- Regeneron Pharmaceuticals' Return on Sales stood at 0.12% in 2022, then sank by 97 bps to 0.0% in 2023, then declined by 28 bps to 0.0% in 2024, then declined by 10 bps to 0.0% in 2025, then jumped by 39 bps to 0.0% in 2026.
- Business Quant data shows REGN's Return on Sales at 0.0% in Q2 2026, 0.0% in Q1 2026, and 0.0% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -2.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.12% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.19% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |